Science ❯ Medical Research ❯ Clinical Trials

Gene Therapy

Huntington's Disease CRISPR-based HIV Therapy Neurosurgery In Vivo Therapy Therapeutic Innovations Innovative Treatments

Gene Therapy Shows 75% Slower Huntington’s Decline in Early Trial

The finding announced last week remains preliminary pending peer review.

Kite Pharma to Buy Interius for $350 Million, Adding In‑Vivo CAR‑T Platform